Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Shareholders??? Equity (Unaudited)

v3.21.1
Condensed Consolidated Statements of Shareholders’ Equity (Unaudited) - USD ($)
Common Stock
Additional Paid In Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2019 $ 10,368 $ 27,757,017 $ (20,626,799) $ 7,140,586
Balance (in Shares) at Dec. 31, 2019 10,368,352      
Equity-based compensation - stock option expense   342,007   342,007
Equity-based compensation - stock issuances to consultants and employees $ 261 345,366   345,627
Equity-based compensation - stock issuances to consultants and employees (in Shares) 261,251      
Net loss     (2,276,813) (2,276,813)
Balance at Mar. 31, 2020 $ 10,629 28,444,390 (22,903,612) 5,551,407
Balance (in Shares) at Mar. 31, 2020 10,629,603      
Balance at Dec. 31, 2020 $ 14,393 35,491,462 (31,519,789) 3,986,066
Balance (in Shares) at Dec. 31, 2020 14,393,100      
Equity-based compensation - stock option expense   473,787   473,787
Equity-based compensation - stock issuances to consultants and employees $ 350 850,550   850,900
Equity-based compensation - stock issuances to consultants and employees (in Shares) 350,000      
Warrants exercised $ 712 1,424,288   1,425,000
Warrants exercised 712,500      
Stock options exercised $ 10 14,490   14,500
Stock options exercised (in Shares) 10,000      
Stock issued as consideration for acquisition $ 700 1,059,450   1,060,150
Stock issued as consideration for acquisition (in Shares) 699,980      
Sale of common stock, net of transaction costs $ 1,105 2,639,898   2,641,003
Sale of common stock, net of transaction costs (in Shares) 1,104,297      
Net loss (4,833,764) (4,833,764)
Balance at Mar. 31, 2021 $ 17,270 $ 41,953,925 $ (36,353,553) $ 5,617,642
Balance (in Shares) at Mar. 31, 2021 17,269,877